186 related articles for article (PubMed ID: 21391003)
1. Handling missing data in vaccine clinical trials for immunogenicity and safety evaluation.
Li X; Wang WW; Liu GF; Chan IS
J Biopharm Stat; 2011 Mar; 21(2):294-310. PubMed ID: 21391003
[TBL] [Abstract][Full Text] [Related]
2. An alternative way to classify missing data mechanism in clinical trials--a dialogue on missing data.
Wei L
J Biopharm Stat; 2011 Mar; 21(2):355-61. PubMed ID: 21391007
[TBL] [Abstract][Full Text] [Related]
3. An overview of practical approaches for handling missing data in clinical trials.
DeSouza CM; Legedza AT; Sankoh AJ
J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
[TBL] [Abstract][Full Text] [Related]
4. Statistical considerations for noninferiority/equivalence trials in vaccine development.
Wang WW; Mehrotra DV; Chan IS; Heyse JF
J Biopharm Stat; 2006; 16(4):429-41. PubMed ID: 16892905
[TBL] [Abstract][Full Text] [Related]
5. Missing data handling in chronic pain trials.
Kim Y
J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
[TBL] [Abstract][Full Text] [Related]
6. Modelling placebo response in depression trials using a longitudinal model with informative dropout.
Gomeni R; Lavergne A; Merlo-Pich E
Eur J Pharm Sci; 2009 Jan; 36(1):4-10. PubMed ID: 19041717
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of methods for analysis of repeated binary responses with missing data.
Frank Liu G; Zhan X
J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
[TBL] [Abstract][Full Text] [Related]
8. Missing data in confirmatory clinical trials.
Flyer P; Hirman J
J Biopharm Stat; 2009 Nov; 19(6):969-79. PubMed ID: 20183459
[TBL] [Abstract][Full Text] [Related]
9. Missing data in the regulation of medical devices.
Campbell G; Pennello G; Yue L
J Biopharm Stat; 2011 Mar; 21(2):180-95. PubMed ID: 21390995
[TBL] [Abstract][Full Text] [Related]
10. Missing data handling methods in medical device clinical trials.
Yan X; Lee S; Li N
J Biopharm Stat; 2009 Nov; 19(6):1085-98. PubMed ID: 20183466
[TBL] [Abstract][Full Text] [Related]
11. Handling missing data issues in clinical trials for rheumatic diseases.
Wong WK; Boscardin WJ; Postlethwaite AE; Furst DE
Contemp Clin Trials; 2011 Jan; 32(1):1-9. PubMed ID: 20840873
[TBL] [Abstract][Full Text] [Related]
12. On the treatment effect in clinical trials with dropout.
Shao J; Zhong B
J Biopharm Stat; 2006; 16(1):25-33. PubMed ID: 16440835
[TBL] [Abstract][Full Text] [Related]
13. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
Kong F; Chen YF; Jin K
J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
[TBL] [Abstract][Full Text] [Related]
14. Analysis of longitudinal binary data with missing data due to dropouts.
Ali MW; Talukder E
J Biopharm Stat; 2005; 15(6):993-1007. PubMed ID: 16279357
[TBL] [Abstract][Full Text] [Related]
15. Type I error and power in noninferiority/equivalence trials with correlated multiple endpoints: an example from vaccine development trials.
Kong L; Kohberger RC; Koch GG
J Biopharm Stat; 2004 Nov; 14(4):893-907. PubMed ID: 15587971
[TBL] [Abstract][Full Text] [Related]
16. Multiple imputation compared with some informative dropout procedures in the estimation and comparison of rates of change in longitudinal clinical trials with dropouts.
Ali MW; Siddiqui O
J Biopharm Stat; 2000 May; 10(2):165-81. PubMed ID: 10803723
[TBL] [Abstract][Full Text] [Related]
17. Statistical considerations for vaccine immunogenicity trials. Part 2: Noninferiority and other statistical approaches to vaccine evaluation.
Plikaytis BD; Carlone GM
Vaccine; 2005 Feb; 23(13):1606-14. PubMed ID: 15694513
[TBL] [Abstract][Full Text] [Related]
18. Missing data issues at the FDA Center for Biologics Evaluation and Research.
Scott JA; Hsu H
J Biopharm Stat; 2011 Mar; 21(2):196-201. PubMed ID: 21390996
[TBL] [Abstract][Full Text] [Related]
19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.
Siddiqui O; Ali MW
J Biopharm Stat; 1998 Nov; 8(4):545-63. PubMed ID: 9855033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
